Flow cytometric analysis of the spleen (A) and bone marrow (B) of a transgenic mouse (Tg) and a nontransgenic control (C) with B220 and anti-CD43 antibodies (4 weeks of age). The transgenic spleen and bone marrow show marked reduction of both B220⁺ CD43⁺ and B220⁺CD43⁻ populations.